Furthermore, in a mouse xenograft model, melatonin inhibited triple-negative breast cancer progression through the Inc049808-FUN14 domain-containing 1 (FUNDC1) pathway [54]. Here, FUNDC1 is linked to triple-negative breast carcinoma.